this was president ultram 2nd chance an effort to calm and comfort the american public as a whole the president had been on the immense pressure and ridicule for what many called a disastrous performance when addressing the nation from the oval office just a few days ago donald trump also announced what he calls an unprecedented federal partnership with private sector foremost with the pharmaceutical and tech industry because of this partnership according to the president hundreds of thousands if not millions more coronavirus tests will be made available across the country no word from the president though on how quickly those tests will finally be available of course it is the profound leg of vailable testing kits and testing itself that has health experts doctors as well as the average american worried and frustrated for weeks. months their reporting from our washington bureau here's a look now at the latest coronavirus developments in italy the hardest hit country in europe it has recorded its highest one day death toll with 250 deaths over the past 24 hours dutch airline kalen pla

rosemary is chair of the board of ultram institute and nonprofit health systems research organizationeadquartered in ann arbor michigan.she graduated summa cum laude from georgetown university and a masters degree from the london school of economics. please join me in welcoming miss rosemary gibson [applause] >> should i take over for now? >> yes. >> the microphone working well back there? wonderful. thank you gentlemen and ladies. good afternoon everyone. doctor goldman, i want to thank you for making this event possible it's a very timely and fitting that we are here at public of school health in the nation's capital to discuss the public health publications as well as national security risks associated with our and growing dependence within a single country within our medicines. the president is set to give a major speech in the coming days and weeks about drug prices. we know many americans are suffering under the burden of the high cost medicines but we have to be mindful of unintended consequences, companies might feel pressure to reduce their prices and reduce their costs, whic